Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA
Millennium Management LLC reported a 4.10% stake in Enanta Pharmaceuticals, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 13, 2025
Millennium Management LLC reported a 4.10% stake in Enanta Pharmaceuticals, Inc., 1,138,484 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 1,138,484
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 4.00% | 1,112,864 |
| Millennium Management LLC | 4.10% | 1,138,484 |
| Millennium Group Management LLC | 4.10% | 1,138,484 |
| Israel A. Englander | 4.10% | 1,138,484 |
Source
Related
- Enanta Pharmaceuticals, Inc.
- Millennium Management LLC
- Enanta Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Jan 20, 2026
- Schedule 13G · Millennium Management LLC · Jan 22, 2025
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 14, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Form 4 · Rottinghaus Scott T. · Aug 10, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Deep Track Capital, LP · Feb 13, 2026